Psychedelics In General Medicine: Use of DMT In Treatment Of Ischemic-Reperfusion Injury.

A tétel rövid nézete
dc.contributor.advisorFrecska, Ede
dc.contributor.advisordeptDebreceni Egyetem: Department Of Psychiatryhu_HU
dc.contributor.authorEbikibina-Oti, Ebieladoh Olusola
dc.contributor.departmentDE--Egészségügyi Karhu_HU
dc.contributor.opponentJuhasz, Bela
dc.contributor.opponentKovács, Attila
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Pszichiátriai Tanszékhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-08-29T09:13:29Z
dc.date.available2022-08-29T09:13:29Z
dc.date.created2022-04-05
dc.description.abstractIschemia can lead to irreversible tissue damage and is also known to be a contributing factor to the development of several cardiovascular diseases; hence reperfusion is needed as soon as possible to prevent the damage or changes from becoming irreversible. A problem that arises from this, is the extra damage that occurs in patients after reperfusion. This paper aims to shed some light on N, N-dimethyltryptamine (DMT) a hallucinogen which has been shown to exert protective effects on several tissues after ischemia-reperfusion (I-R) event by acting on a chaperone protein known as the sigma-1 Receptor. Thus, DMT possesses therapeutic potential regarding ischemic pathologies.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent30hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336855
dc.language.isoenhu_HU
dc.subjectSigma-1 Receptorhu_HU
dc.subjectDimethyltryptaminehu_HU
dc.subject.dspaceDEENK Témalista::Pszichológiahu_HU
dc.titlePsychedelics In General Medicine: Use of DMT In Treatment Of Ischemic-Reperfusion Injury.hu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)